News
HQY
83.08
-0.41%
-0.34
Why HealthEquity (HQY) is Poised to Beat Earnings Estimates Again
NASDAQ · 1d ago
Weekly Report: what happened at HQY last week (0219-0223)?
Weekly Report · 2d ago
RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $90
Benzinga · 5d ago
Analysts Offer Insights on Healthcare Companies: C4 Therapeutics (CCCC), Insulet (PODD) and Healthequity (HQY)
TipRanks · 5d ago
Buy Rating Affirmed for HealthEquity: A Path to Doubling EPS Through Strategic Growth and Innovation
TipRanks · 5d ago
Barclays Sticks to Its Buy Rating for Healthequity (HQY)
TipRanks · 5d ago
Healthequity: A Strong Buy on Robust Financial Outlook and Consistent Performance
TipRanks · 6d ago
HealthEquity Reports Year-End Sales Metrics; Sees FY24 EPS $2.20-$2.24 Vs $2.14 Est.; Revenue $995M-$1B Vs $992.74M Est.; FY25 Revenue $1.14B-$1.16B Vs $1.15B Est.;
Company revises its business outlook for the fiscal year ended January 31, 2024. Company affirms its previously provided outlook for fiscal year ending January 31,. 2025. The Company's business outlook assumes an average annualized yield on HSA cash of approximately 3%. The Company uses non-GAAP financial measures.
Benzinga · 6d ago
Weekly Report: what happened at HQY last week (0212-0216)?
Weekly Report · 02/19 09:04
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Moderna (MRNA) and Alnylam Pharma (ALNY)
Healthequity, Moderna and Alnylam Pharma have 3 analysts with bullish sentiments on the Healthcare sector. 3 analysts just reiterated a Buy rating on Heal thequity (HQY) and Moderna (MRNA – Research Report) in a report released today. The analysts also maintain Buy ratings on the stocks of Healthe quity, moderna and alnylam.
TipRanks · 02/16 12:50
Quest Diagnostics (DGX) Boosts Oncology Portfolio With New Test
NASDAQ · 02/15 12:58
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Ironwood Pharma (IRWD) and Healthequity (HQY)
TipRanks · 02/14 11:50
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Alector (ALEC) and Cytokinetics (CYTK)
Healthequity (HQY) and Alector (ALEC) have 3 analysts with bullish sentiments on the Healthcare sector. 3 analysts just issued buy ratings on Healthequy, Cytokinetics (CYTK) and Cytokinetics. The 3 companies are in the same sector.
TipRanks · 02/13 10:27
Here's Why You Should Add HealthEquity (HQY) to Your Portfolio
NASDAQ · 02/12 15:30
Zacks Industry Outlook Highlights Elevance Health, Cencora and HealthEquity
NASDAQ · 02/12 11:00
Weekly Report: what happened at HQY last week (0205-0209)?
Weekly Report · 02/12 09:03
More
Webull provides a variety of real-time HQY stock news. You can receive the latest news about Healthequity Inc through multiple platforms. This information may help you make smarter investment decisions.
About HQY
HealthEquity, Inc. is engaged in providing technology-enabled services that help consumers make healthcare savings and spending decisions. The Company uses its technology to manage consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It offers a mutual fund investment platform and access to an online-only automated investment advisory service to all its members. It offers multiple cloud-based platforms, accessed by its members online via a desktop or mobile device, through which individuals can make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings and make investment choices.